Prostate Cancer Reports
54

Volume 6 Number 1
January 2018

.

Home > Prostate Cancer Reports > Volume 6, Year 2018 > Number 1, January



CONTENTS



CLASSIFICATION
DIAGNOSIS
ETIOLOGY, PATHOGENESIS, PATHOLOGY
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



CLASSIFICATION



Porter LH, Lawrence MG, Ilic D, Clouston D, Bolton DM, Frydenberg M, Murphy DG, Pezaro C, Risbridger GP, Taylor RA.
Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.
Eur Urol. 2017 Oct;72(4):492-495. doi: 10.1016/j.eururo.2017.03.013. Epub 2017 Mar 22.
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.
J Urol. 2017 Dec;198(6):1208-1211. doi: 10.1016/j.juro.2017.09.063. Epub 2017 Sep 15.
Source | Abstract | Full text | Similar articles



DIAGNOSIS



Evangelista L.
Editorial Comment.
J Urol. 2016 May;195(5):1442-3. doi: 10.1016/j.juro.2015.12.107. Epub 2016 Feb 5.
Comment on: Maurer T et al, Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. [ J Urol. 2016 May]
Source | Abstract | Full text | Similar articles




Gómez-de la Fuente FJ, Martínez-Rodríguez I, de Arcocha-Torres M, Quirce R, Jiménez-Bonilla J, Martínez-Amador N, Banzo I.
Contribution of 11C-Choline PET/CT in prostate carcinoma biochemical relapse with serum PSA level below 1 ng/ml.
Rev Esp Med Nucl Imagen Mol. 2017 Nov 11. pii: S2253-654X(17)30162-2. doi: 10.1016/j.remn.2017.10.001. [Epub ahead of print] English, Spanish.
Source | Abstract | Full text | Similar articles




Hassan O, Han M, Zhou A, Paulk A, Sun Y, Al-Harbi A, Alrajjal A, Baptista Dos Santos F, Epstein JI.
Incidence of Extra-Prostatic Extension at Radical Prostatectomy with Pure Gleason Score 3+3=6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed as "not Cancer" and for Selection Criteria for Active Surveillance.
J Urol. 2017 Nov 15. pii: S0022-5347(17)77915-3. doi: 10.1016/j.juro.2017.11.067. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




[No authors listed]
Reply by Authors.
J Urol. 2016 May;195(5):1443. doi: 10.1016/j.juro.2015.12.108. Epub 2016 Feb 5.
Comment on: Evangelista L., Editorial Comment. [ J Urol. 2016 May]
Source | Abstract | Full text | Similar articles




Oderda M, Joniau S, Palazzetti A, Falcone M, Melloni G, Van Den Bossche H, Deconinck S, Zattoni F, Karnes RJ, Gontero P.
Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy
European Urology Focus, DOI: http://dx.doi.org/10.1016/j.euf.2015.12.004
Source | Abstract | Full text




Rhee H, Thomas P, Shepherd B, Gustafson S, Vela I, Russell PJ, Nelson C, Chung E, Wood G, Malone G, Wood S, Heathcote P.
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer.
J Urol. 2016 Oct;196(4):1261-7. doi: 10.1016/j.juro.2016.02.3000. Epub 2016 May 21.
Source | Abstract | Full text | Similar articles




Taneja SS.
Re: Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
J Urol. 2017 Dec;198(6):1209-1210. doi: 10.1016/j.juro.2017.09.064. Epub 2017 Sep 15.
Source | Abstract | Full text | Similar articles




Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G, Wester HJ, Heck M, Kübler H, Beer AJ, Schwaiger M, Eiber M.
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.
J Urol. 2016 May;195(5):1436-43. doi: 10.1016/j.juro.2015.12.025. Epub 2015 Dec 9.
Source | Abstract | Full text | Similar articles




Wibmer AG, Vargas HA, Hricak H.
Prostate cancer in 2017: Advances in imaging.
Nat Rev Urol. 2017 Dec 12. doi: 10.1038/nrurol.2017.210. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY



Chen WY, Tsai YC, Yeh HL, Suau F, Jiang KC, Shao AN, Huang J, Liu YN.
Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
Sci Signal. 2017 Aug 15;10(492). pii: eaam6826. doi: 10.1126/scisignal.aam6826.
Source | Abstract | Full text | Similar articles




Tsai YC, Liu YN.
New ideas in preventing castration-resistant prostate cancer.
Oncotarget. 2017 Sep 30;8(49):84628-84629. doi: 10.18632/oncotarget.21396. eCollection 2017 Oct 17.
Source | Abstract | Full text | Similar articles



INTEGRATIVE MEDICINE



Mohebbati R, Anaeigoudari A, Khazdair MR.
The effects of Curcuma longa and curcumin on reproductive systems.
Endocr Regul. 2017 Oct 26;51(4):220-228. doi: 10.1515/enr-2017-0024.
Source | Abstract | Full text | Similar articles



OVERALL MANAGEMENT



Dong DX, Ji ZG.
Current Progress and Controversies in Prostate Cancer Management.
Chin Med J (Engl). 2017 Dec 20;130(24):2991-2995. doi: 10.4103/0366-6999.220317 .
Source | Abstract | Full text | Similar articles



PROGNOSIS



Bjurlin MA, Rosenkrantz AB, Sarkar S, Lepor H, Huang WC, Huang R, Venkataraman R, Taneja SS.
Prediction of Prostate Cancer Risk among Men Undergoing Combined MRI-Targeted and Systematic Biopsy Using Novel Pre-Biopsy Nomograms That Incorporate MRI Findings.
Urology. 2017 Nov 16. pii: S0090-4295(17)31185-8. doi: 10.1016/j.urology.2017.09.035. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kane CJ, Eggener SE, Shindel AW, Andriole GL.
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review.
Eur Urol Focus. 2017 Mar 11. pii: S2405-4569(16)30157-2. doi: 10.1016/j.euf.2016.10.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




March B, Koufogiannis G, Louie-Johnsun M.
Management and outcomes of Gleason six prostate cancer detected on needle biopsy: A single-surgeon experience over 6 years.
Prostate Int. 2017 Dec;5(4):139-142. doi: 10.1016/j.prnil.2017.03.007. Epub 2017 Apr 7.
Source | Abstract | Full text | Similar articles




Thalgott M, Kron M, Brath JM, Ankerst DP, Thompson IM, Gschwend JE, Herkommer K.
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.
World J Urol. 2017 Nov 21. doi: 10.1007/s00345-017-2122-5. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P.
Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study.
Ann Oncol. 2017 Nov 17. doi: 10.1093/annonc/mdx742. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yang DD, Mahal BA, Muralidhar V, Vastola ME, Boldbaatar N, Labe SA, Nezolosky MD, Orio PF 3rd, King MT, Martin NE, Mouw KW, Trinh QD, Nguyen PL.
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.
Clin Genitourin Cancer. 2017 Nov 9. pii: S1558-7673(17)30329-4. doi: 10.1016/j.clgc.2017.10.013. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



TREATMENT



Ahmad AE, Leão R, Hamilton RJ.
Radical Prostatectomy for Patients With Oligometastatic Prostate Cancer.
Oncology (Williston Park). 2017 Nov 15;31(11):794-802.
Source | Abstract | Full text | Similar articles




Artibani W, Porcaro AB, De Marco V, Cerruto MA, Siracusano S.
Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.
Urol Int. 2017 Nov 21. doi: 10.1159/000481438. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Buonerba C, Di Lorenzo G.
The Sooner, the Better: The Establishment of a Treatment Paradigm in Prostate Cancer.
Front Pharmacol. 2017 Oct 31;8:788. doi: 10.3389/fphar.2017.00788. eCollection 2017.
Source | Abstract | Full text | Similar articles




Dal Pra A, Zilli T, Supiot S.
Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer.
Front Oncol. 2017 Nov 23;7:275. doi: 10.3389/fonc.2017.00275. eCollection 2017.
Source | Abstract | Full text | Similar articles




Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.
Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Eur Urol. 2017 Dec 8. pii: S0302-2838(17)31005-9. doi: 10.1016/j.eururo.2017.11.020. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Gandaglia G, Tilki D, Zaffuto E, Fossati N, Pompe RS, Dell'Oglio P, Graefen M, Montorsi F, Briganti A.
Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions.
Eur Urol Focus. 2017 Nov 16. pii: S2405-4569(17)30253-5. doi: 10.1016/j.euf.2017.10.013. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Moul JW.
Counterpoint: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy?
Oncology (Williston Park). 2017 Nov 15;31(11):830, 833-5.
Source | Abstract | Full text | Similar articles




Usón PLS Junior, Macarenco RSES, Oliveira FN, Smaletz O.
Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer.
Clin Med Insights Pathol. 2017 Nov 2;10:1179555717740130. doi: 10.1177/1179555717740130. eCollection 2017.
Source | Abstract | Full text | Similar articles




Yu JB, Hamstra D.
Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy?
Oncology (Williston Park). 2017 Nov 15;31(11):830-2, 835.
Source | Abstract | Full text | Similar articles